Mark Kirschbaum
Officer at Cyclacel Pharmaceuticals, Inc. (BGMS)
Mark Kirschbaum has filed 3 insider reports with the SEC since December 2021, as officer at Cyclacel Pharmaceuticals, Inc. (BGMS). The latest filing, on July 3, 2023, reports grant or award at Cyclacel Pharmaceuticals, Inc. (BGMS).
- Filings
- 3
- Companies
- 1
- Bought on market
- None
- Sold on market
- None
Companies where Mark Kirschbaum is an insider
| Company | Role | Shares held | Bought | Sold | Avg buy | Price now | Last filing |
|---|---|---|---|---|---|---|---|
| Officer | 31,200 | $0.6109 | Jul 3, 2023 |
Shares held: common shares owned directly after the latest filing that states it. Avg buy: open-market purchase dollars divided by shares bought, every filing on record.
Every filing
- Jun 30, 2023BGMSSEC Form 4 filed by Kirschbaum MarkForm 4Grant or award
- Jan 31, 2023BGMSSEC Form 4: Kirschbaum Mark was granted 31,200 sharesForm 4Grant or award
- Dec 13, 2021BGMSSEC Form 4 filed by Kirschbaum MarkForm 4Grant or award
Compare Mark Kirschbaum with
- Mark Kirschbaum vs Doris Wong Sing Ee1 shared
- Mark Kirschbaum vs Cu Seng Kiu1 shared
- Mark Kirschbaum vs Yee Lung Ong1 shared
- Mark Kirschbaum vs Khai Loon Kua1 shared
- Mark Kirschbaum vs Kim Choy Yap1 shared
- Mark Kirschbaum vs Diversified Berhad Fitters1 shared
Other insiders at the same companies
- Cu Seng KiuBGMS
- Doris Wong Sing EeBGMS
- Kim Choy YapBGMS
- Khai Loon KuaBGMS
- Yee Lung OngBGMS
- Diversified Berhad FittersBGMS
- David E. LazarBGMS
- Kok Hui TanBGMS
- Suria Sukses Engineering Sdn BhdBGMS
- Kee Wee HoBGMS
- Jien Shiung HoBGMS
- Inigo Angel LaurdurajBGMS
- Nair Krishnan Satis WaranBGMS
- David NatanBGMS
- Avraham Ben-TzviBGMS
- Kwang Fock ChongBGMS
Questions about Mark Kirschbaum
- What is Mark Kirschbaum's role at Cyclacel Pharmaceuticals, Inc.?
- Mark Kirschbaum reports to the SEC as officer at Cyclacel Pharmaceuticals, Inc. (BGMS), according to the latest filing on July 3, 2023.
- How many shares does Mark Kirschbaum own?
- After the latest filing that states it, Mark Kirschbaum directly owned 31,200 shares of Cyclacel Pharmaceuticals, Inc. (BGMS). Shares held through trusts, funds or family members are reported separately and are not counted here.
- Has Mark Kirschbaum bought or sold stock recently?
- No open-market purchases or sales by Mark Kirschbaum are on file. The filings report grant or award.
- How do I get alerts when Mark Kirschbaum files?
- Follow Mark Kirschbaum on Quantisnow and you get an email, and a phone notification on Plus, within minutes of each new Form 4 or Form 5, and of each Form 144 notice of a planned sale.
From SEC Forms 3, 4, 5 and 144 filed by Mark Kirschbaum (SEC CIK 0001830211). Totals count each trade once, skipping amendments whose original is on file, from Dec 15, 2021 on. View on SEC EDGAR · Get this as JSON